Last reviewed · How we verify

NCT05428813

The Effect of Art on Premenstrual Syndrome Symptoms

Completed NA Last updated 15 February 2023
What this trial tests

NA trial testing art therapy techniques in Premenstrual Syndrome in 72 participants. Completed in 30 December 2022.

Timeline
15 April 2022
Primary endpoint
15 September 2022
30 December 2022

Quick facts

Lead sponsorKutahya Health Sciences University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment72
Start date15 April 2022
Primary completion15 September 2022
Estimated completion30 December 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kutahya Health Sciences University

Who can join

Adults 18 to 30, female only, with Premenstrual Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be conducted to determine the effect of art therapy techniques on premenstrual syndrome symptoms.The study is a randomized controlled type study. The study will be conducted with 70 female students with premenstrual syndrome. In the study, which consists of two groups, experimental (n=35) and control (n=35), art therapy techniques will be applied to the students in the experimental group for 8 weeks. The control group will continue their routine coping habits. Both groups will be evaluated with the Premenstrual Syndrome scale at the end of the study, and the difference between the groups will be examined.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Premenstrual Syndrome

Currently open trials in the same condition.

Other Kutahya Health Sciences University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05428813.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing